Current Assets

Equipment Installment Plan Receivables, Gross

Royalty Pharma Equipment Installment Plan Receivables, Gross decreased by 2.0% to $20.04B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.3%, from $19.41B to $20.04B. Over 5 years (FY 2020 to FY 2025), Equipment Installment Plan Receivables, Gross shows an upward trend with a 7.5% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: eip_receivables_gross

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$14.82B$16.02B$16.03B$15.92B$16.05B$17.25B$16.78B$16.90B$16.86B$17.11B$17.89B$17.77B$18.50B$19.36B$19.70B$19.41B$19.44B$20.09B$20.46B$20.04B
QoQ Change—+8.1%+0.0%-0.7%+0.8%+7.5%-2.7%+0.7%-0.2%+1.5%+4.5%-0.7%+4.1%+4.6%+1.8%-1.5%+0.1%+3.4%+1.8%-2.0%
YoY Change————+8.3%+7.6%+4.7%+6.1%+5.1%-0.8%+6.7%+5.2%+9.7%+13.1%+10.1%+9.2%+5.0%+3.8%+3.9%+3.3%
Range$14.82B – $20.46B
CAGR+6.6%
Avg YoY Growth+6.3%
Median YoY Growth+5.7%

Frequently Asked Questions

What is Royalty Pharma's equipment installment plan receivables, gross?
Royalty Pharma (RPRX) reported equipment installment plan receivables, gross of $20.04B in Q1 2026.
How has Royalty Pharma's equipment installment plan receivables, gross changed year-over-year?
Royalty Pharma's equipment installment plan receivables, gross increased by 3.3% year-over-year, from $19.41B to $20.04B.
What is the long-term trend for Royalty Pharma's equipment installment plan receivables, gross?
Over 5 years (2020 to 2025), Royalty Pharma's equipment installment plan receivables, gross has grown at a 7.5% compound annual growth rate (CAGR), from $14.22B to $20.46B.